Cargando…

Mismatch Negativity as a “Translatable” Brain Marker Toward Early Intervention for Psychosis: A Review

Recent reviews and meta-analyses suggest that reducing the duration of untreated psychosis leads to better symptomatic and functional outcome in patients with psychotic disorder. Early intervention attenuates the symptoms of individuals at clinical high-risk (HR) for psychosis and may delay or preve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagai, Tatsuya, Tada, Mariko, Kirihara, Kenji, Araki, Tsuyoshi, Jinde, Seiichiro, Kasai, Kiyoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779867/ https://www.ncbi.nlm.nih.gov/pubmed/24069006 http://dx.doi.org/10.3389/fpsyt.2013.00115

Ejemplares similares

Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis
por: Fujioka, Mao, et al.
Publicado: (2020)

A Predictive Coding Perspective on Mismatch Negativity Impairment in Schizophrenia
por: Kirihara, Kenji, et al.
Publicado: (2020)

Translatability of Scalp EEG Recordings of Duration-Deviant Mismatch Negativity Between Macaques and Humans: A Pilot Study
por: Tada, Mariko, et al.
Publicado: (2020)

Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis
por: Nagai, Tatsuya, et al.
Publicado: (2017)

Reduced Auditory Mismatch Negativity Reflects Impaired Deviance Detection in Schizophrenia
por: Koshiyama, Daisuke, et al.
Publicado: (2020)

Prediction-Related Frontal-Temporal Network for Omission Mismatch Activity in the Macaque Monkey
por: Suda, Yuki, et al.
Publicado: (2022)

Auditory Steady State Response; nature and utility as a translational science tool
por: Kozono, Naoki, et al.
Publicado: (2019)

Spatiotemporal Differentiation of MMN From N1 Adaptation: A Human ECoG Study
por: Takasago, Megumi, et al.
Publicado: (2020)

Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Mismatch Negativity: Translating the Potential
por: Todd, Juanita, et al.
Publicado: (2013)

Longitudinal change in mismatch negativity (MMN) but not in gamma-band auditory steady-state response (ASSR) is associated with psychological difficulties in adolescence
por: Usui, Kaori, et al.
Publicado: (2023)

Alterations of auditory-evoked gamma oscillations are more pronounced than alterations of spontaneous power of gamma oscillation in early stages of schizophrenia
por: Tada, Mariko, et al.
Publicado: (2023)

Criticality in the Healthy Brain
por: Shi, Jifan, et al.
Publicado: (2022)

Mismatch Negativity and Impaired Social Functioning in Long-Term and in First Episode Schizophrenia Spectrum Psychosis
por: Murphy, Timothy K., et al.
Publicado: (2020)

Progressive Impairment of Mismatch Negativity Is Reflective of Underlying Pathophysiological Changes in Patients With First-Episode Psychosis
por: Lho, Silvia Kyungjin, et al.
Publicado: (2020)

Auditory Mismatch Negativity in Youth Affected by Autism Spectrum Disorder With and Without Attenuated Psychosis Syndrome
por: Di Lorenzo, Giorgio, et al.
Publicado: (2020)

Mismatch negativity generation in subjects at risk for psychosis: source analysis is more sensitive than surface electrodes in risk prediction
por: Aeberli, Tina, et al.
Publicado: (2023)

Making Sense of Mismatch Negativity
por: Fitzgerald, Kaitlin, et al.
Publicado: (2020)

Surface area in the insula was associated with 28-month functional outcome in first-episode psychosis
por: Koike, Shinsuke, et al.
Publicado: (2021)

Global and Parallel Cortical Processing Based on Auditory Gamma Oscillatory Responses in Humans
por: Tada, Mariko, et al.
Publicado: (2021)

Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets
por: Schultze-Lutter, Frauke, et al.
Publicado: (2016)

Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity
por: Kawakubo, Yuki, et al.
Publicado: (2011)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Nakajima, Suguru, et al.
Publicado: (2021)

Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
por: Kim, Helena K., et al.
Publicado: (2020)

Auditory Mismatch Negativity Under Predictive Coding Framework and Its Role in Psychotic Disorders
por: Fong, Chun Yuen, et al.
Publicado: (2020)

Bi-Directional Relationships Between Psychological Symptoms and Environmental Factors in Early Adolescence
por: Huang, Ziyan, et al.
Publicado: (2020)

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2017)

Reductions in Complex Mismatch Negativity to Extra Tone Gestalt Pattern Deviance in First-Episode Schizophrenia
por: Salisbury, Dean F., et al.
Publicado: (2020)

Forecasting prognostic trajectories with mismatch negativity in early psychosis
por: Kim, Minah, et al.
Publicado: (2023)

Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis
por: Mørch-Johnsen, Lynn, et al.
Publicado: (2022)

Near-Infrared Spectroscopy in Schizophrenia: A Possible Biomarker for Predicting Clinical Outcome and Treatment Response
por: Koike, Shinsuke, et al.
Publicado: (2013)

Anatomical Templates of the Midbrain Ventral Tegmental Area and Substantia Nigra for Asian Populations
por: Nakamura, Yuko, et al.
Publicado: (2018)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
por: Devoe, Daniel J., et al.
Publicado: (2023)

Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia
por: Francis, Ashley M., et al.
Publicado: (2020)

A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology
por: Wearne, Travis A., et al.
Publicado: (2018)

Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
por: Gjerde, Priyanthi B., et al.
Publicado: (2022)

Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol
por: Sandström, Katharina O., et al.
Publicado: (2022)

Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up
por: Pappa, Sofia, et al.
Publicado: (2023)

Being Praised for Prosocial Behaviors Longitudinally Reduces Depressive Symptoms in Early Adolescents: A Population-Based Cohort Study
por: Nagaoka, Daiki, et al.
Publicado: (2022)

Corrigendum: Being praised for prosocial behaviors longitudinally reduces depressive symptoms in early adolescents: a population-based cohort study
por: Nagaoka, Daiki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vufrf5sn8qvi27pq0p0on5jp30